ROWLAND LLOYD A 4
4 · CytomX Therapeutics, Inc. · Filed Mar 20, 2025
Insider Transaction Report
Form 4
ROWLAND LLOYD A
General Counsel
Transactions
- Sale
Common Stock
2025-03-18$0.60/sh−10,203$6,112→ 120,594 total
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]Includes 30,624 RSUs.